Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.89 Billion CNY | 15.6% |
| 2022 | 1.5 Billion CNY | 32.19% |
| 2021 | 1.13 Billion CNY | 3.54% |
| 2020 | 1.09 Billion CNY | 22.21% |
| 2019 | 898.92 Million CNY | 11.28% |
| 2018 | 807.76 Million CNY | 28.25% |
| 2017 | 629.84 Million CNY | 25.73% |
| 2016 | 500.93 Million CNY | 85.65% |
| 2015 | 269.83 Million CNY | -1.55% |
| 2014 | 274.07 Million CNY | 71.04% |
| 2013 | 160.23 Million CNY | 87.29% |
| 2012 | 85.55 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 543.38 Million CNY | 1.73% |
| 2024 Q1 | 451.66 Million CNY | -9.29% |
| 2024 Q2 | 534.14 Million CNY | 18.26% |
| 2023 Q1 | 405.71 Million CNY | -8.35% |
| 2023 FY | 1.73 Billion CNY | 15.6% |
| 2023 Q4 | 497.92 Million CNY | -0.7% |
| 2023 Q3 | 501.42 Million CNY | 9.05% |
| 2023 Q2 | 459.81 Million CNY | 13.33% |
| 2022 FY | 1.5 Billion CNY | 32.19% |
| 2022 Q1 | 358.71 Million CNY | -2.03% |
| 2022 Q4 | 442.66 Million CNY | 8.68% |
| 2022 Q3 | 407.29 Million CNY | 38.09% |
| 2022 Q2 | 294.95 Million CNY | -17.78% |
| 2021 FY | 1.13 Billion CNY | 3.54% |
| 2021 Q4 | 366.12 Million CNY | 32.75% |
| 2021 Q3 | 275.79 Million CNY | -5.63% |
| 2021 Q1 | 203.23 Million CNY | -29.05% |
| 2021 Q2 | 292.26 Million CNY | 43.81% |
| 2020 Q1 | 127.05 Million CNY | -48.75% |
| 2020 Q4 | 286.46 Million CNY | 10.71% |
| 2020 FY | 1.09 Billion CNY | 22.21% |
| 2020 Q2 | 426.29 Million CNY | 235.53% |
| 2020 Q3 | 258.74 Million CNY | -39.3% |
| 2019 Q3 | 257.87 Million CNY | 10.87% |
| 2019 Q2 | 232.59 Million CNY | 44.85% |
| 2019 Q1 | 160.58 Million CNY | 0.0% |
| 2019 Q4 | 247.88 Million CNY | -3.87% |
| 2019 FY | 898.92 Million CNY | 11.28% |
| 2018 FY | 807.76 Million CNY | 28.25% |
| 2017 FY | 629.84 Million CNY | 25.73% |
| 2016 Q1 | 103.82 Million CNY | 91.91% |
| 2016 FY | 500.93 Million CNY | 85.65% |
| 2016 Q4 | 134.4 Million CNY | 0.0% |
| 2016 Q3 | 134.4 Million CNY | 29.45% |
| 2016 Q2 | 103.82 Million CNY | 0.0% |
| 2015 Q3 | 54.1 Million CNY | -26.87% |
| 2015 Q2 | 73.98 Million CNY | -0.0% |
| 2015 Q1 | 73.98 Million CNY | -6.28% |
| 2015 Q4 | 54.1 Million CNY | 0.0% |
| 2015 FY | 269.83 Million CNY | -1.55% |
| 2014 FY | 274.07 Million CNY | 71.04% |
| 2014 Q2 | 57.63 Million CNY | -0.0% |
| 2014 Q1 | 57.63 Million CNY | 16.9% |
| 2014 Q4 | 78.94 Million CNY | 0.0% |
| 2014 Q3 | 78.94 Million CNY | 36.98% |
| 2013 Q2 | 30.8 Million CNY | 0.0% |
| 2013 Q4 | 49.29 Million CNY | 0.0% |
| 2013 FY | 160.23 Million CNY | 87.29% |
| 2013 Q3 | 49.29 Million CNY | 60.05% |
| 2013 Q1 | 30.8 Million CNY | 0.0% |
| 2012 FY | 85.55 Million CNY | 0.0% |